Abstract
Objective: To evaluate incidence and mortality of congenital heart disease in very low birthweight babies.
Method: Retrospective analysis of a 12 year period.
Results: Forty seven babies were diagnosed with severe congenital heart disease. The most common lesions were ventricular septal defect and coarctation of the aorta. Mortality attributed to congenital heart disease was 32%. Coarctation of the aorta, the second most common lesion, was fatal in 62% of cases. Closure of a patent ductus arteriosus with indomethacin proved to be detrimental in babies with undiagnosed coarctation, causing rapid deterioration in some.
Conclusion: Very low birthweight neonates with severe congenital heart disease have a higher mortality than babies with higher birth weight. A contributing factor is closure of a patent ductus arteriosus if an underlying lesion has not been recognised. This could be of significance if the use of prophylactic treatment with indomethacin becomes more common.
Full Text
The Full Text of this article is available as a PDF (82.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Allan L. D., Sharland G. K., Milburn A., Lockhart S. M., Groves A. M., Anderson R. H., Cook A. C., Fagg N. L. Prospective diagnosis of 1,006 consecutive cases of congenital heart disease in the fetus. J Am Coll Cardiol. 1994 May;23(6):1452–1458. doi: 10.1016/0735-1097(94)90391-3. [DOI] [PubMed] [Google Scholar]
- Borowski A., Schickendantz S., Mennicken U., Korb H. Open heart interventions in premature low- and very-low-birth-weight neonates: risk profile and ethical considerations. Thorac Cardiovasc Surg. 1997 Oct;45(5):238–241. doi: 10.1055/s-2007-1013734. [DOI] [PubMed] [Google Scholar]
- Chang A. C., Hanley F. L., Lock J. E., Castaneda A. R., Wessel D. L. Management and outcome of low birth weight neonates with congenital heart disease. J Pediatr. 1994 Mar;124(3):461–466. doi: 10.1016/s0022-3476(94)70376-0. [DOI] [PubMed] [Google Scholar]
- Dees E., Lin H., Cotton R. B., Graham T. P., Dodd D. A. Outcome of preterm infants with congenital heart disease. J Pediatr. 2000 Nov;137(5):653–659. doi: 10.1067/mpd.2000.108568. [DOI] [PubMed] [Google Scholar]
- Fowlie P. W. Prophylactic indomethacin: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 1996 Mar;74(2):F81–F87. doi: 10.1136/fn.74.2.f81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grabitz R. G., Joffres M. R., Collins-Nakai R. L. Congenital heart disease: incidence in the first year of life. The Alberta Heritage Pediatric Cardiology Program. Am J Epidemiol. 1988 Aug;128(2):381–388. doi: 10.1093/oxfordjournals.aje.a114978. [DOI] [PubMed] [Google Scholar]
- Hoffman J. I. Incidence of congenital heart disease: I. Postnatal incidence. Pediatr Cardiol. 1995 May-Jun;16(3):103–113. doi: 10.1007/BF00801907. [DOI] [PubMed] [Google Scholar]
- Hoffman J. I. Incidence of congenital heart disease: II. Prenatal incidence. Pediatr Cardiol. 1995 Jul-Aug;16(4):155–165. doi: 10.1007/BF00794186. [DOI] [PubMed] [Google Scholar]
- Kidd S. A., Lancaster P. A., McCredie R. M. The incidence of congenital heart defects in the first year of life. J Paediatr Child Health. 1993 Oct;29(5):344–349. doi: 10.1111/j.1440-1754.1993.tb00531.x. [DOI] [PubMed] [Google Scholar]
- Marino B. S., Bird G. L., Wernovsky G. Diagnosis and management of the newborn with suspected congenital heart disease. Clin Perinatol. 2001 Mar;28(1):91–136. doi: 10.1016/s0095-5108(05)70071-3. [DOI] [PubMed] [Google Scholar]
- Ment L. R., Oh W., Ehrenkranz R. A., Philip A. G., Vohr B., Allan W., Duncan C. C., Scott D. T., Taylor K. J., Katz K. H. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics. 1994 Apr;93(4):543–550. [PubMed] [Google Scholar]
- Ment L. R., Vohr B., Oh W., Scott D. T., Allan W. C., Westerveld M., Duncan C. C., Ehrenkranz R. A., Katz K. H., Schneider K. C. Neurodevelopmental outcome at 36 months' corrected age of preterm infants in the Multicenter Indomethacin Intraventricular Hemorrhage Prevention Trial. Pediatrics. 1996 Oct;98(4 Pt 1):714–718. [PubMed] [Google Scholar]
- Numa A., Butt W., Mee R. B. Outcome of infants with birthweight 2000 g or less who undergo major cardiac surgery. J Paediatr Child Health. 1992 Aug;28(4):318–320. doi: 10.1111/j.1440-1754.1992.tb02676.x. [DOI] [PubMed] [Google Scholar]
- Pawade A., Waterson K., Laussen P., Karl T. R., Mee R. B. Cardiopulmonary bypass in neonates weighing less than 2.5 kg: analysis of the risk factors for early and late mortality. J Card Surg. 1993 Jan;8(1):1–8. doi: 10.1111/j.1540-8191.1993.tb00570.x. [DOI] [PubMed] [Google Scholar]
- Reddy V. M., McElhinney D. B., Sagrado T., Parry A. J., Teitel D. F., Hanley F. L. Results of 102 cases of complete repair of congenital heart defects in patients weighing 700 to 2500 grams. J Thorac Cardiovasc Surg. 1999 Feb;117(2):324–331. doi: 10.1016/S0022-5223(99)70430-7. [DOI] [PubMed] [Google Scholar]
- Rossi A. F., Seiden H. S., Sadeghi A. M., Nguyen K. H., Quintana C. S., Gross R. P., Griepp R. B. The outcome of cardiac operations in infants weighing two kilograms or less. J Thorac Cardiovasc Surg. 1998 Jul;116(1):28–35. doi: 10.1016/S0022-5223(98)70239-9. [DOI] [PubMed] [Google Scholar]
- Schmidt B., Davis P., Moddemann D., Ohlsson A., Roberts R. S., Saigal S., Solimano A., Vincer M., Wright L. L., Trial of Indomethacin Prophylaxis in Preterms Investigators Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med. 2001 Jun 28;344(26):1966–1972. doi: 10.1056/NEJM200106283442602. [DOI] [PubMed] [Google Scholar]